Great post. Really, I think it all boils down to how quickly/how much they can sell the Medivet business for. Like I posted in the announcement thread, I think a company selling off non-core parts of the business to focus on profitable or growth areas is always encouraging.
I looked at this one a while ago over 10c, and while it seemed like a good business, I didn't see the potential for big SP growth. Looking at it now, the market cap of the business has halved and removing the Medivet business leaves a nicely profitable business that is growing well. The only issue is if they can't sell quickly they don't have enough cash in the bank to carry the dead weight for more than a quarter or two.
MLA Price at posting:
6.6¢ Sentiment: None Disclosure: Not Held
